Paper Details

  1. Home
  2. Paper Details

Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.

Author: BekkeringGeertruida E, KramersCornelis, Van den NoortgateWim, VerbeeckWim

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

ADHD is a common condition affecting attention, impulsivity, and activity levels, leading to difficulties in school and work. While stimulant medications are the usual treatment, not everyone responds well or tolerates them. Bupropion, a medication used for depression and smoking cessation, is sometimes used "off-label" (not officially approved) to treat ADHD.
Paper Details　
Original Abstract of the Article :
Attention deficit hyperactivity disorder (ADHD) is a prevalent neurobiological condition, characterised by behavioral and cognitive symptoms such as inattention, impulsivity and/or excessive activity. The syndrome is commonly accompanied by psychiatric comorbidities and is associated with educationa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485546/

データ提供：米国国立医学図書館（NLM）

Exploring Alternative Treatment Options for ADHD: The Potential of Bupropion

The journey of [attention deficit hyperactivity disorder (ADHD)] can be challenging for individuals struggling with [inattention, impulsivity, and excessive activity]. This research investigates the potential of [bupropion], an [aminoketone antidepressant], as an alternative treatment for [adult ADHD]. The authors review the existing literature on bupropion's efficacy for managing ADHD symptoms and discuss its advantages and limitations compared to traditional [psychostimulant medications]. This study sheds light on a promising avenue for individuals who may not respond well to or tolerate psychostimulants.

Beyond Psychostimulants: Exploring Non-Stimulant Options

This research highlights the need for diverse treatment options for individuals with ADHD. The authors explore the potential of bupropion as a viable alternative for adults who may not respond well to or tolerate psychostimulants. Bupropion's unique mechanism of action as a [non-competitive antagonist of nicotinic acetylcholine receptors] offers a promising alternative for individuals seeking relief from ADHD symptoms. While further research is needed to fully understand its long-term efficacy and safety, this study provides a valuable starting point for exploring non-stimulant treatment options for ADHD.

Finding the Right Path: A Personalized Approach to ADHD Management

The journey to finding the right treatment for ADHD can be long and winding. This research reminds us that there's no one-size-fits-all approach to managing this condition. It's crucial to consider individual patient needs and preferences when developing a treatment plan. This study provides valuable information that can inform the development of personalized treatment strategies for individuals with ADHD, potentially leading to improved outcomes and a better quality of life.

Dr. Camel's Conclusion

Imagine a vast desert, dotted with hidden oases offering respite from the harsh conditions. ADHD is like a traveler navigating this desert, seeking the right path to manage their symptoms. This research explores a new oasis, offering a potential alternative treatment option in bupropion. The study underscores the importance of personalized medicine and the need for diverse treatment options for individuals with ADHD. It's a reminder that the search for effective treatments is ongoing, and we're continually striving to improve the lives of those with this condition.

Date :
  1. Date Completed 2018-10-04
  2. Date Revised 2021-07-14
Further Info :

Pubmed ID

28965364

DOI: Digital Object Identifier

PMC6485546

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.